Browsing by Author "Islam, Shofiqul"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    Distribution of Essential and Non-Essential Elements in Rice-Based Products Sold in Australian Markets: Exposure Assessment
    (Elsevier, 2023-07-15) Sarkar, Md Imran Ullah; Islam, Shofiqul; Hosain, Md. Tofail; Naidu, Ravi; Rahman, Mohammad Mahmudur
    Rice-derived food products could be a major dietary source of both essential and non-essential elements to people; hence it is crucial to assess their concentrations to ensure the safe consumption of these products. In this study, six different types of rice-based products collected from Australian markets were analysed for essential and non-essential elements to evaluate the exposure and health risk. The estimated intake (EI) of essential elements from baby rice substantially contributed to the recommended dietary allowance of Fe (27%) and Mn (43%) for infants compared to different rice-based products for children and adults. The EI values of Cd, Cr, Ni and Pb were 0.15 – 1.17, 5.68 – 16.24, 7.47 – 16.24 and 0.40 – 1.21 µg, respectively, from an average recommended serving of different rice-based products. Compared to the tolerable daily intake (TDI) and tolerable weekly intake (TWI) provided by the European Food Safety Authority (EFSA), both average daily intake (ADI) and average weekly intake (AWI) values of the respective non-essential elements were much lower. Thus, this study results indicated that the rice-based products pose no potential health risk to consumers although regular monitoring is necessary to reduce health risks especially for infants and children.
  • Thumbnail Image
    Item
    Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey
    (Lancet, 2011-08-28) Yusuf, Salim; Islam, Shofiqul; Chow, Clara K.; Rangarajan, Sumathy; Rahman, Omar; et al
    The research was aimed to assess use of proven eff ective secondary preventive drugs (antiplatelet drugs, β blockers, angiotensin-converting-enzyme [ACE] inhibitors or angiotensin-receptor blockers [ARBs], and statins) in individuals with a history of coronary heart disease or stroke.